Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (451-460 of 529) with videos related to

Pageof 53
Sort By:
Biomolecules|January 21, 2022
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade ChemotherapyArin Nam, Atish Mohanty, Supriyo Bhattacharya, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 20, 2012
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and SurveillanceFrancine L Jacobson, John H M Austin, John K Field, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 20, 2012
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groupsMichael T Jaklitsch, Francine L Jacobson, John H M Austin, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Molecular Cancer Therapeutics|July 17, 2016
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to CetuximabMari Iida, Harsh Bahrar, Toni M Brand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Cancer Research|January 7, 2006
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesotheliomaRamasamy Jagadeeswaran, Patrick C Ma, Tanguy Y Seiwert, et al.
Cancer Cell|January 9, 2026
The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapyAndrea H Bild, Michelle C Sangar, Jasmine A McQuerry, et al.
Pageof 53

Showing results (451-460 of 529) with videos related to

Sort By:
Pageof 53
Biomolecules|January 21, 2022
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade ChemotherapyArin Nam, Atish Mohanty, Supriyo Bhattacharya, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 20, 2012
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and SurveillanceFrancine L Jacobson, John H M Austin, John K Field, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 20, 2012
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groupsMichael T Jaklitsch, Francine L Jacobson, John H M Austin, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Molecular Cancer Therapeutics|July 17, 2016
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to CetuximabMari Iida, Harsh Bahrar, Toni M Brand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Cancer Research|January 7, 2006
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesotheliomaRamasamy Jagadeeswaran, Patrick C Ma, Tanguy Y Seiwert, et al.
Cancer Cell|January 9, 2026
The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapyAndrea H Bild, Michelle C Sangar, Jasmine A McQuerry, et al.
Pageof 53